Abbott plans marketing push for glucose monitors beyond diabetes

Abbott Laboratories (ABT.N) will use a mix of TV advertisements and guerilla marketing as well as seek to personalize health data to tap people without diabetes for the U.S. launch of its glucose monitoring device, CEO Robert Ford said on Thursday.